We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

In a report released on January 27, Jessica Fye from J.P. Morgan maintained a Buy rating on Intra-Cellular Therapies (ITCI – Research Report), ...

Shares of Intra-Cellular Therapies are surging 35% in premarket trading Monday after Johnson & Johnson said it will acquire ...

Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...

We recently compiled a list of the Why These 10 Large-Cap Stocks are Skyrocketing. In this article, we are going to take a look at where Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) stands against the ...

Investment analysts at StockNews.com assumed coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) in a research report issued to clients and investors on Thursday.

In the preceding three months, 6 analysts have released ratings for Intra-Cellular Therapies (NASDAQ:ITCI), presenting a wide array of perspectives from bullish to bearish. The table below ...